P16INK4a Negative Oropharyngeal Squamous Cell Carcinoma
Also known as: Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB14547 | Chloride ion | 2 | Recruiting | 1 |
DB00515 | Cisplatin | 2 | Recruiting | 1 |
DB12257 | Platinum | 2 | Recruiting | 1 |
DB11595 | Atezolizumab | 2 / 3 | Recruiting | 1 |
DB11595 | Atezolizumab | 2 / 3 | Suspended | 1 |
DB00002 | Cetuximab | 2 / 3 | Recruiting | 1 |
DB00002 | Cetuximab | 2 / 3 | Suspended | 1 |
DB14547 | Chloride ion | 2 / 3 | Recruiting | 1 |
DB14547 | Chloride ion | 2 / 3 | Suspended | 1 |
DB00515 | Cisplatin | 2 / 3 | Recruiting | 1 |
DB00515 | Cisplatin | 2 / 3 | Suspended | 1 |
DB01248 | Docetaxel | 2 / 3 | Recruiting | 1 |
DB01248 | Docetaxel | 2 / 3 | Suspended | 1 |
DB12257 | Platinum | 2 / 3 | Recruiting | 1 |
DB12257 | Platinum | 2 / 3 | Suspended | 1 |